Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTracsis Regulatory News (TRCS)

Share Price Information for Tracsis (TRCS)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -5.00 (-1.52%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £96.78m
TRCS Live PriceLast checked at - London Stock Exchange

Intraday Tracsis Share Chart

Director/PDMR Shareholding

17 Jul 2014 07:54

RNS Number : 5781M
Tracsis PLC
17 July 2014
 



 

Tracsis plc

 

("Tracsis" or the "Company")

 

Directors Dealing - Exercise of Options

 

Tracsis announces that it received on 16 July 2014, notice of exercise of options from the following Directors:

 

John McArthur, Chief Executive Officer, exercised 140,000 options at an exercise price of 52p per share from a share option agreement dated 2009. No shares were sold in order to satisfy exercise costs. As a result of this, Mr McArthur's interests in the company increased to 1,112,474 representing 4.2% of the total voting rights of the Company.

 

Max Cawthra, Finance Director, exercised 75,000 options at an exercise price of 49.5p per share from a share option agreement dated 2011. In order to satisfy exercise costs 25,000 shares were subsequently disposed at a price of £3.11. As a result of this transaction, Mr Cawthra's interests in the company increased from 4,000 to 54,000 representing 0.2% of the total voting rights of the Company.

 

Charles Winward, a Non-Executive Director exercised 87,517 options at an exercise price of 40p per share from a share option agreement dated 2007. In order to satisfy exercise costs, income tax, national insurance and other liabilities arising 57,246 shares were subsequently disposed at a price of £3.11. As a result of this transaction Mr Winward's interests in the company will increase from 56,500 to 86,771 representing 0.3% of the total voting rights of the Company.

 

A summary of these transactions and resulting Directors' holdings in Tracsis is as follows:

 

Share holding prior to exercise

Option holding prior to exercise

Options exercised today

Shares sold today

Resulting Share

Holding

% of issued share capital

Non-Executive Directors

Chris Cole (Chair)

-

-

-

-

-

-

Sean Lippell

-

50,000

-

-

-

-

John Nelson

230,824

25,000

-

-

230,824

0.9%

Charles Winward

56,500

137,517

87,517

(57,246)

86,771

0.3%

Executive Directors

Max Cawthra

4,000

235,162

75,000

(25,000)

54,000

0.2%

John McArthur

972,474

240,000

140,000

-

1,112,474

4.2%

Total Interest

1,263,798

687,679

302,517

(82,246)

1,484,069

5.6%

 

 

Accordingly, the Company has today issued 302,517 ordinary shares in the Company "new ordinary shares". Application has been made for the new ordinary shares to be admitted to trading on AIM and dealings are expected to commence on 22 July 2014.

 

Following the issue of the new shares, the number of Ordinary Shares in issue will increase to 26,258,114. For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following this allotment consists of 26,258,114 Shares with voting rights attached (one vote per Share). There are no shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Tracsis under the DTRs.

 

 

For more information please contact:

 

John McArthur/Max Cawthra, Tracsis plc

 

Tel: 0845 125 9162

Katy Mitchell, WH Ireland Limited

Tel: 0161 832 2174

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKMGMNVNFGDZG
Date   Source Headline
1st Sep 20237:02 amRNSDirectorate Change
1st Sep 20237:01 amRNSBlock Listing Return
1st Sep 20237:00 amRNSTotal Voting Rights
23rd Aug 20237:00 amRNSTrading Update and Notice of Results
1st Aug 20237:00 amRNSTotal Voting Rights
27th Jul 20237:00 amRNSDirectorate Change
3rd Jul 20237:00 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSTotal Voting Rights
5th May 20238:10 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSInterim Results
3rd Apr 20237:00 amRNSTotal Voting Rights
1st Mar 20237:02 amRNSListing Application
1st Mar 20237:01 amRNSBlock Listing Return
1st Mar 20237:00 amRNSTotal Voting Rights
23rd Feb 20237:00 amRNSTrading Update and Notice of Results
1st Feb 20237:00 amRNSTotal Voting Rights
18th Jan 20233:15 pmRNSResult of AGM
16th Jan 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
3rd Jan 20237:00 amRNSTotal Voting Rights
7th Dec 20227:01 amRNSGrant of Options
7th Dec 20227:00 amRNSAnnual Report and Notice of AGM
1st Dec 20227:00 amRNSTotal Voting Rights
18th Nov 20227:00 amRNSDirector/PDMR Shareholding
9th Nov 20227:00 amRNSFinal Results
1st Nov 20227:00 amRNSTotal Voting Rights
5th Oct 20227:00 amRNSBoard Changes
3rd Oct 20227:00 amRNSTotal Voting Rights
1st Sep 20227:01 amRNSTotal Voting Rights
1st Sep 20227:00 amRNSBlock Listing Return
24th Aug 20227:00 amRNSTrading Update and Notice of Results
1st Aug 20227:00 amRNSTotal Voting Rights
22nd Jul 20224:15 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSTotal Voting Rights
4th May 202212:20 pmRNSDirector/PDMR Shareholding and Total Voting Rights
3rd May 20227:00 amRNSTotal Voting Rights
7th Apr 20227:00 amRNSInterim Results
1st Apr 20227:00 amRNSTotal Voting Rights
14th Mar 20227:00 amRNSNorth American Rail Acquisition
1st Mar 20227:02 amRNSListing Application
1st Mar 20227:01 amRNSBlock Listing Return
1st Mar 20227:00 amRNSTotal Voting Rights
23rd Feb 20227:00 amRNSTrading Update and Notice of Results
1st Feb 20227:00 amRNSTotal Voting Rights
18th Jan 20222:45 pmRNSResult of AGM
14th Jan 20224:31 pmRNSHolding(s) in Company
4th Jan 20227:00 amRNSTotal Voting Rights
17th Dec 20217:00 amRNSAnnual Report and Notice of AGM
1st Dec 20217:00 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSGrant of options
12th Nov 202112:38 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.